These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16237753)

  • 1. Dendritic cells pulsed with hsp70-peptide complexes derived from human hepatocellular carcinoma induce specific anti-tumor immune responses.
    Wang XH; Qin Y; Hu MH; Xie Y
    World J Gastroenterol; 2005 Sep; 11(36):5614-20. PubMed ID: 16237753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells pulsed with gp96-peptide complexes derived from human hepatocellular carcinoma (HCC) induce specific cytotoxic T lymphocytes.
    Wang XH; Qin Y; Hu MH; Xie Y
    Cancer Immunol Immunother; 2005 Oct; 54(10):971-80. PubMed ID: 15965645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells pulsed with Hsp70 and HBxAg induce specific antitumor immune responses in hepatitis B virus-associated hepatocellular carcinoma.
    Wang H; Feng F; Wang XP; Wang RS; Wu Y; Zhu MG; Zhang H; Zhuang ZX
    Mol Med Rep; 2016 Feb; 13(2):1077-82. PubMed ID: 26647961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved efficacy of therapeutic vaccination with dendritic cells pulsed with tumor cell lysate against hepatocellular carcinoma by introduction of 2 tandem repeats of microbial HSP70 peptide epitope 407-426 and OK-432.
    Ge C; Xing Y; Wang Q; Xiao W; Lu Y; Hu X; Gao Z; Xu M; Ma Y; Cao R; Liu J
    Int Immunopharmacol; 2011 Dec; 11(12):2200-7. PubMed ID: 22015603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells].
    Wang ZH; Ye Q; Hu ZQ; Ye ZQ; Yu X; Shen GX
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):481-5. PubMed ID: 17147108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inducing hepatocellular carcinoma-specific cytotoxic T lymphocyte response using formed by fusion of FastDCs and allogeneic human hepatocellular carcinoma cells].
    Guan X; Leng XS; Peng JR; Wei YH; Wang H; Yuan L
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3332-6. PubMed ID: 16409838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced immunity against hepatoma induced by dendritic cells pulsed with Hsp70-H22 peptide complexes and CD40L.
    Gao J; Luo SM; Peng ML; Deng T
    J Cancer Res Clin Oncol; 2012 Jun; 138(6):917-26. PubMed ID: 22327301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-loaded dendritic cells triggers a specific cytotoxic T lymphocytes immune response against hepatocellular carcinoma: in vitro study.
    El-Ashmawy NE; El-Zamarany EA; Khedr EG; El-Bahrawy HA; El-Feky OA
    Clin Transl Oncol; 2019 May; 21(5):636-645. PubMed ID: 30368725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of specific cytolytic T lymphocytes using fusions of hepatocellular carcinoma (HCC) patient-derived dendritic cells and allogeneic HCC cell line.
    Yin XY; Wang L; Lu MD; Li BJ; Huang JF
    Hepatogastroenterology; 2008; 55(81):155-9. PubMed ID: 18507097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat-shock protein 70 as a tumor antigen for in vitro dendritic cell pulsing in renal cell carcinoma cases.
    Meng FD; Sui CG; Tian X; Li Y; Yang CM; Ma P; Liu YP; Jiang YH
    Asian Pac J Cancer Prev; 2014; 15(20):8947-50. PubMed ID: 25374234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new purification method for enhancing the immunogenicity of heat shock protein 70-peptide complexes.
    Gao Y; Chen X; Gao W; Yang Y; Ma H; Ren X
    Oncol Rep; 2012 Dec; 28(6):1977-83. PubMed ID: 23007635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An in vitro study of specific antitumor immunity induced by dendritic cells pulsed with tumor cell lysates from patients with hepatocellular carcinoma].
    Gao J; Chen M; Peng ML; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):198-201. PubMed ID: 15760555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy based on dendritic cells pulsed with CTPFoxM1 fusion protein protects against the development of hepatocellular carcinoma.
    Su H; Li B; Zheng L; Wang H; Zhang L
    Oncotarget; 2016 Jul; 7(30):48401-48411. PubMed ID: 27351282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells.
    Koido S; Homma S; Hara E; Mitsunaga M; Namiki Y; Takahara A; Nagasaki E; Komita H; Sagawa Y; Ohkusa T; Fujise K; Gong J; Tajiri H
    J Transl Med; 2008 Sep; 6():51. PubMed ID: 18793383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
    Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
    Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma.
    Tomimaru Y; Mishra S; Safran H; Charpentier KP; Martin W; De Groot AS; Gregory SH; Wands JR
    Vaccine; 2015 Mar; 33(10):1256-66. PubMed ID: 25629522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells.
    Noessner E; Gastpar R; Milani V; Brandl A; Hutzler PJ; Kuppner MC; Roos M; Kremmer E; Asea A; Calderwood SK; Issels RD
    J Immunol; 2002 Nov; 169(10):5424-32. PubMed ID: 12421917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritomas formed by fusion of mature dendritic cells with allogenic human hepatocellular carcinoma cells activate autologous cytotoxic T lymphocytes.
    Chan RC; Xie H; Zhao GP; Xie Y
    Immunol Lett; 2002 Sep; 83(2):101-9. PubMed ID: 12067758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock treatment of tumor lysate-pulsed dendritic cells enhances their capacity to elicit antitumor T cell responses against medullary thyroid carcinoma.
    Bachleitner-Hofmann T; Strohschneider M; Krieger P; Sachet M; Dubsky P; Hayden H; Schoppmann SF; Pfragner R; Gnant M; Friedl J; Stift A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4571-7. PubMed ID: 16954161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing the treatment effect on melanoma by heat shock protein 70-peptide complexes purified from human melanoma cell lines.
    Gao Y; Gao W; Chen X; Cha N; Wang X; Jia X; Wang B; Ren M; Ren J
    Oncol Rep; 2016 Sep; 36(3):1243-50. PubMed ID: 27431432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.